Search

Your search keyword '"Decristoforo, Clemens"' showing total 772 results

Search Constraints

Start Over You searched for: Author "Decristoforo, Clemens" Remove constraint Author: "Decristoforo, Clemens"
772 results on '"Decristoforo, Clemens"'

Search Results

2. Highlight selection of radiochemistry and radiopharmacy developments by editorial board.

6. Highlight selection of radiochemistry and radiopharmacy developments by editorial board.

11. [111In]In-CP04 as a novel cholecystokinin-2 receptor ligand with theranostic potential in patients with progressive or metastatic medullary thyroid cancer: final results of a GRAN-T-MTC Phase I clinical trial

12. Highlight selection of radiochemistry and radiopharmacy developments by editorial board.

13. Highlight selection of radiochemistry and radiopharmacy developments by editorial board (January-June 2020).

17. Practical considerations for navigating the regulatory landscape of non-clinical studies for clinical translation of radiopharmaceuticals

19. Editorial Board

26. Impact of forced diuresis with furosemide and hydration on the halo artefact and intensity of tracer accumulation in the urinary bladder and kidneys on [68Ga]Ga-PSMA-11-PET/CT in the evaluation of prostate cancer patients

27. Advancing 6-bromo-7-[11C]methylpurine to clinical use: improved regioselective radiosynthesis, non-clinical toxicity data and human dosimetry estimates.

32. PET and SPECT

36. Management of NENs with SSTR2-antagonist: how close are we to a clinical solution? The first results of the TECANT study: Novel 99m-Tc-labelled somatostatin antagonists in the diagnostic algorithm of neuroendocrine neoplasms - a feasibility study

37. Molecular Design of 68Ga- and 89Zr-Labeled Anticalin Radioligands for PET-Imaging of PSMA-Positive Tumors

42. Development of the 99mTc-Labelled SST2 Antagonist TECANT-1 for a First-in-Man Multicentre Clinical Study

44. Improved Quality Control of [177Lu]Lu-PSMA I&T

45. Preclinical pharmacokinetics, biodistribution, radiation dosimetry and toxicity studies required for regulatory approval of a phase I clinical trial with 111In-CP04 in medullary thyroid carcinoma patients

47. 18th European Symposium on Radiopharmacy and Radiopharmaceuticals: Salzburg, Austria. 7-10 April 2016

Catalog

Books, media, physical & digital resources